Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Makiko Sakata is active.

Publication


Featured researches published by Makiko Sakata.


World Journal of Surgery | 2009

Aberrant Methylation of the Netrin-1 Receptor Genes UNC5C and DCC Detected in Advanced Colorectal Cancer

Kenji Hibi; Hiroki Mizukami; Atsushi Shirahata; Tetsuhiro Goto; Makiko Sakata; Yutaka Sanada

BackgroundUNC5C and DCC, the netrin-1 receptors, belong to the functional dependence receptors family, which shares the ability to induce apoptosis in the absence of their ligands. Recently, two reports indicated that UNC5C and DCC methylation was closely associated with loss of gene expression in colorectal cancer. These results prompted us to examine the methylation status of the UNC5C and DCC genes in the colorectal carcinomas we surgically removed.MethodsThe methylation status of the UNC5C and DCC genes were examined in primary carcinomas and the corresponding normal tissues derived from 50 patients with colorectal cancer using quantitative methylation-specific polymerase chain reaction (qMSP). The correlation between the methylation status and the clinicopathologic findings was then evaluated.ResultsAberrant methylation of the netrin-1 receptor genes were detected in 41 of the 50 (82%) primary colon cancers, suggesting that the aberrant methylation of netrin-1 receptors was frequently observed in colorectal cancer. The clinicopathologic data were then correlated with this result.ConclusionsA significant difference was observed in the Dukes stage (p = 0.0438). Netrin-1 receptors might act as a tumor suppressor in colorectal cancers, and thus methylation might present a malignant potential in colorectal cancer.


Hepato-gastroenterology | 2012

Methylation of the WNT5A gene is frequently detected in early gastric carcinoma.

Kenji Hibi; Makiko Sakata; Yokomizi K; Youhei Kitamura; Kazuma Sakuraba; Shirahata R; Tetsuhiro Goto; Hiroki Mizukami; Mitsuo Saito; Kazuyoshi Ishibashi; Gaku Kigawa; Hiroshi Nemoto; Yutaka Sanada

BACKGROUND/AIMS Recently, it has been reported that WNT5A methylation was frequently detected in colorectal cancers. However, the relationship between the WNT5A methylation and the characteristics of gastric cancer remains unknown. METHODOLOGY Methylation status of the WNT5A gene was examined in primary carcinomas and the corresponding normal tissues derived from 38 patients with gastric cancer using quantitative methylation-specific PCR (qMSP) and the correlation between the methylation status and the clinicopathological findings was evaluated. RESULTS Aberrant methylation of the WNT5A gene was detected in 7 out of the 38 (18%) primary gastric carcinomas, suggesting that the methylation of WNT5A is observed in gastric carcinomas as well as colorectal ones. The clinicopathological data were correlated with the methylation results. A significant difference was observed in the extent of tumor (p=0.0226). Moreover, a trend was shown towards early TNM stages in methylated tumors (p=0.209). CONCLUSIONS WNT5A was more frequently methylated in early gastric carcinomas.


Anticancer Research | 2009

Aberrant Methylation of the UNC5C Gene is Frequently Detected in Advanced Colorectal Cancer

Kenji Hibi; Hiroki Mizukami; Atsushi Shirahata; Tetsuhiro Goto; Makiko Sakata; Mitsuo Saito; Kazuyoshi Ishibashi; Gaku Kigawa; Hiroshi Nemoto; Yutaka Sanada


Anticancer Research | 2010

MACC 1 as a Marker for Peritoneal-disseminated Gastric Carcinoma

Atsushi Shirahata; Makiko Sakata; Youhei Kitamura; Kazuma Sakuraba; Kazuaki Yokomizo; Tetsuhiro Goto; Hiroki Mizukami; Mitsuo Saito; Kazuyoshi Ishibashi; Gaku Kigawa; Hiroshi Nemoto; Kenji Hibi


Anticancer Research | 2009

Vimentin Methylation as a Marker for Advanced Colorectal Carcinoma

Atsushi Shirahata; Makiko Sakata; Kazuma Sakuraba; Tetsuhiro Goto; Hiroki Mizukami; Mitsuo Saito; Kazuyoshi Ishibashi; Gaku Kigawa; Hiroshi Nemoto; Yutaka Sanada; Kenji Hibi


Anticancer Research | 2009

Aberrant Methylation of the p16 Gene Is Frequently Detected in Advanced Colorectal Cancer

Tetsuhiro Goto; Hiroki Mizukami; Atsushi Shirahata; Makiko Sakata; Mitsuo Saito; Kazuyoshi Ishibashi; Gaku Kigawa; Hiroshi Nemoto; Yutaka Sanada; Kenji Hibi


Anticancer Research | 2009

Methylation of HACE1 in Gastric Carcinoma

Makiko Sakata; Yo-Hei Kitamura; Kazuma Sakuraba; Tetsuhiro Goto; Hiroki Mizukami; Mitsuo Saito; Kazuyoshi Ishibashi; Gaku Kigawa; Hiroshi Nemoto; Yutaka Sanada; Kenji Hibi


Anticancer Research | 2008

PGP9.5 methylation as a marker for metastatic colorectal cancer.

Hiroki Mizukami; Atsushi Shirahata; Tetsuhiro Goto; Makiko Sakata; Mitsuo Saito; Kazuyoshi Ishibashi; Gaku Kigawa; Hiroshi Nemoto; Yutaka Sanada; Kenji Hibi


Anticancer Research | 2009

Down-regulation of Tip60 Gene as a Potential Marker for the Malignancy of Colorectal Cancer

Kazuma Sakuraba; Takashi Yasuda; Makiko Sakata; Yo-Hei Kitamura; Atsushi Shirahata; Tetsuhiro Goto; Hiroki Mizukami; Mitsuo Saito; Kazuyoshi Ishibashi; Gaku Kigawa; Hiroshi Nemoto; Yutaka Sanada; Kenji Hibi


Anticancer Research | 2009

Demethylation of the CDH3 Gene Is Frequently Detected in Advanced Colorectal Cancer

Kenji Hibi; Tetsuhiro Goto; Hiroki Mizukami; Yo-Hei Kitamura; Kazuma Sakuraba; Makiko Sakata; Mitsuo Saito; Kazuyoshi Ishibashi; Gaku Kigawa; Hiroshi Nemoto; Yutaka Sanada

Collaboration


Dive into the Makiko Sakata's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge